[Federal Register: January 28, 2003 (Volume 68, Number 18)]
[Notices]               
[Page 4218-4219]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr28ja03-95]                         


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES


Centers for Disease Control and Prevention


 
Healthcare Infection Control Practices Advisory Committee 
(HICPAC): Meeting


    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.


    Name: Healthcare Infection Control Practices Advisory Committee.
    Times and Dates: 8:30 a.m.-5 p.m., February 24, 2003; 8:30 a.m.-
4 p.m., February 25, 2003.
    Place: Swissotel, 3391 Peachtree Road, NE, Atlanta, Georgia 
30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with providing advice and 
guidance to the Secretary, HHS, the Director, CDC, the Director, 
National Center for Infectious Diseases (NCID), and the Director, 
Division of Healthcare Quality Promotion; NCID, regarding (1) the 
practice of hospital infection strategies for surveillance, 
prevention, and control of healthcare-associated infections (e.g., 
nosocomial infections), antimicrobial resistance, and related events 
in settings where healthcare is provided; and (2) periodic updating 
of guidelines and other policy statements regarding prevention of 
healthcare-associated infections and healthcare-related conditions.
    Matters To Be Discussed: Agenda items will include a review of 
the Draft Guideline for Preventing Transmission of Infectious Agents 
in Healthcare Settings (formerly Guideline for Isolation Precautions 
in Hospitals); the Draft Guideline for Disinfection and 
Sterilization in Healthcare Settings; the Draft Guideline for 
Prevention of Healthcare-associated Pneumonia; infection control 
issues related to smallpox and vaccinia; injection safety in 
ambulatory healthcare settings; and updates on CDC activities of 
interest to the committee.


[[Page 4219]]


    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Michele L. Pearson, M.D., 
Executive Secretary, HICPAC, Division of Healthcare Quality 
Promotion, NCID, CDC, 1600 Clifton Road, NE, M/S A-07, Atlanta, 
Georgia 30333, telephone 404/498-1182.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.


    Dated: January 22, 2003.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 03-1825 Filed 1-27-03; 8:45 am]

BILLING CODE 4163-18-P